Effect of Crocus sativus L. (Saffron) on coagulation and anticoagulation systems in healthy volunteers

Phytotherapy Research

Volumn 28, Issue 4, 2014, Pages 539-543

  Ayatollahi, Hossein ^a   Javan, Atefeh Ordoei ^b   Khajedaluee, Mohammad ^b   Shahroodian, Masood ^c   Hosseinzadeh, Hossein ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Sarvar Specialized Polyclinic Lab   (Iran)

Author keywords

anticoagulant; clinical trial; coagulation; Crocus sativus; platelet aggregation; saffron

Indexed keywords

BLOOD CLOTTING FACTOR 7; CROCUS SATIVUS EXTRACT; FIBRINOGEN; PLACEBO; PROTEIN C; PROTEIN S;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; TABLET;

CROCUS SATIVUS;

ANTICOAGULANT; CLINICAL TRIAL; COAGULATION; CROCUS SATIVUS; PLATELET AGGREGATION; SAFFRON;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION; CROCUS; DOUBLE-BLIND METHOD; FACTOR VII; FEMALE; FIBRINOGEN; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; PROTEIN C; PROTEIN S; PROTHROMBIN TIME; TABLETS; YOUNG ADULT;

EID: 84898005743     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5021     Document Type: Article

References (35)

1. Abdullaev FI,. 1994. Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett 70: 2887-2898.
2. Agha-Hosseini M, Kashani L, Aleyaseen A, et al,. 2008. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 115: 515-519.
3. Akhondzadeh BA, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S,. 2007. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Progr Neuro Psychopharmacol Biol Psychiatr 31: 439-442.
4. Chan K-C, Yin M-C, Chao W-J,. 2007. Effect of diallyl trisulfide-rich garlic oil on blood coagulation and plasma activity of anticoagulation factors in rats. Food Chem Toxicol 45: 502-507.
5. Chang PY, Wang CK, Liang CT, Kuo W,. 1964. The pharmacological action of Zang Hong Hua (Crocus sativus). I. effects on the uterus and estrous cycle. Yao Hsueh Hsueh Pao 11: 94-100.
6. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L,. 2005. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis 16: 597-605.
7. Hariri AT, Moallem SA, Mahmoudi M, Hosseinzadeh H,. 2011. The effect of crocin and safranal, constituents of saffron, against subacute effect of diazinon on hematological and genotoxicity indices in rats. Phytomedicine 18: 499-504.
8. Hariri AT, Moallem SA, Mahmoudi M, Memar B, Hosseinzadeh H,. 2010. Sub-acute effects of diazinon on biochemical indices and specific biomarkers in rats: protective effects of crocin and safranal. Food Chem Toxicol 48: 2803-2808.
9. Hempel CJ,. 1865. A New and Comprehensive System of Materia Medica and Therapeutics, Arranged Upon a Physiologico-Pathological Basis: For the Use of Practitioners and Students of Medicine, Vol: 2, 2nd edn. W. Radde: New York, NY, 241.
10. Hosseinzadeh H, Younesi H,. 2002. Petal and stigma extracts of Crocus sativus L. have antinociceptive and anti-inflammatory effects in mice. BMC Pharmacol 2: 7.
11. Hosseinzadeh H, Karimi G, Niapoor M,. 2004. Antidepressant effect of Crocus sativus l. stigma extracts and their constituents, crocin and safranal, in mice. Acta Hort 650: 435-445.
12. Hosseinzadeh H, Sadeghnia HR,. 2007. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine 14: 256-62.
13. Hosseinzadeh H, Shamsaie F, Mehri S,. 2009. Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus l. stigma and its bioactive constituent, crocin and safranal. Pharmacog Mag 5: 419-424.
14. Hosseinzadeh H, Talebzadeh F,. 2005. Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia 76: 722-4.
15. Hosseinzadeh H, Ziaee T, Sadeghi A,. 2008 The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine 15: 491-495.
16. Jessie SW, Krishnakantha TP,. 2005. Inhiition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron. J Mol Cell Biochem 278: 59-63.
17. Kianbakht S, Ghazavi A,. 2005. Evaluation of immunological and hematological effects of saffron in men. Ethnopharmacologia 36: 78-83.
18. Lemini C, Jaimez R, Franco Y,. 2007. Gender and inter-species influence on coagulation tests of rats and mice. Thromb Res 120: 415-9.
19. Liakopoulou-Kyriakides M, Sinakos Z, Kyriakidis DA,. 1985. A high molecular weight platelet aggregating factor in Crocus sativus. Plant Sci J 40: 117-20.
20. Liakopoulou-Kyriakides M, Skubas AI,. 1990. Characterization of the platelet aggregation inducer and inhibitor isolated from Crocus sativus. Biochem. Int. J 22: 103-110.
21. Ma SP, Liu BL, Zhou SD, Xu XW, Yang QQ, Zhou JX,. 1999. Pharmacological studies of glycosides of saffron (Crocus sativus): effect on blood coagulation, platelet aggregation and thrombosis. J Chin Tradit Herb Drugs 30: 196-198.
22. Meadows TA, Bhatt DL,. 2007. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res 100: 1261-1275.
23. Modaghegh MH, Shahabian M, Esmaeili H, Rajbai O, Hosseinzadeh H,. 2008. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine 15: 1032-37.
24. Mohamadpour AH, Ayati Z, Parizadeh M-R, Rajbai O, Hosseinzadeh H,. 2013. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci. 16: 39-46.
25. Nair S, Salomi MJ, Varghese CD, Panikkar B, Panikkar KB,. 1992. Effect of saffron on thymocute proliferation, intracellular gluthation levels and its antitumor activity. Biofactors 4: 51-4.
26. Okano K, Nishio T, Fukaya C, Yokoyama K, Nishimoto T, Matsumoto K,. 1992. Isolation and identification of a platelet aggregation inhibitor from saffron (Crocus sativus Linne, Iridaceae). Wakan Iyaku Gakkaishi 9: 175-181.
27. O'Kennedy N, Crosbie L, Van Lieshout M, Broom JI, Webb DJ, Duttaroy AK,. 2006. Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: A time-course cannulation study in healthy humans. Am J Clin Nutr 84: 570-579.
28. Rezaee R, Hosseinzadeh H,. 2013. Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci 16: 12-26.
29. Ríos JL, Recio MC, Giner RM, Máňez S,. 1996. An update review of saffron and its active constituents. Phytother Res 10: 189-193.
30. Sadeghnia HR, Cortez MA, Liu D, Hosseinzadeh H, Snead OC,. 2008 Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography. J Pharm Pharm Sci 11: 1-14.
31. Schmidt M, Betti G, Hensel A,. 2007 Saffron in phytotherapy: Pharmacology and clinical uses. Wien Med Wochenschr 157: 315-319.
32. Shamsa A, Hosseinzadeh H, Molaei M, Shakeri MT, Rajabi O,. 2009. Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study. Phytomedicine 16: 690-693.
33. Verma SK, Bordia A,. 1998. Antioxidant property of saffron in man. Indian J Med Sci 52: 205-207.
34. 2+ in the inhibition by crocetin of platelet activity and thrombosis formation. J Agric Food Chem 56: 9429-9433.
35. Yang Y, Qian Z-Y,. 2007. Effect of crocetin on platelet aggregation in rats. Chin J Nat Med 5: 374-378.